Table 5. MDR analysis to detect two-locus disease models.
Women | Gene | Model | TA | Sing test (P-value) | P-value * | CVC | |
1 | Dectin-2 | rs7134303 | 0.5402 | 3 (P = 0.95) | NS | 9/10 | |
2 | Dectin-2 | rs4264222, rs7134303 | 0.5560 | 8 (P = 0.05) | 0.007 | 9/10 | |
Men | Gene | Model | TA | Sing test (P-value) | P-value * | CVC | |
1 | DC-SIGN | rs2287886 | 0.5424 | 9 (P = 0.01) | NS | 10/10 | |
2 | MCP-1, DC-SIGN | rs13900, rs2287886 | 0.4738 | 5 (P = 0.62) | NS | 3/10 |
TA, Testing accuracy; CVC, Cross-validation consistency. P<0.05 was considered significant. NS, not significant.
P-value for testing balanced accuracy using 1.000-fold permutation test (MDR permutation testing module vs.0.4.9 alpha).